Evidence map›Paper›PMID 35859319›Full record

ArticleNeuropathology : official journal of the Japanese Society of Neuropathology2022

A case of CIC-rearranged sarcoma with CIC-LEUTX gene fusion in spinal cord.

Kun Song, Yu Huang, Chun-Duo Xia, Hai-Qing Zhu, Juan Wang

Open access · hybridAbstract readCase Reports
In one paragraph

Article in Neuropathology : official journal of the Japanese Society of Neuropathology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Primary Intracranial CIC-Rearranged Sarcoma With Prior History of B-Cell ALL: A Case Report.Neuropathology : official journal of the Japanese Society of Neuropathology · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Molecular and therapeutic advancements in Capicua (Frontiers in cell and developmental biology · 2024
    Review
  8. Review
  9. Expanding the Molecular Diversity of CIC-Rearranged Sarcomas With Novel and Very Rare Partners.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2023
    Article
  10. Review
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kun SongDepartment of Pathology, Brain Hospital Affiliated to Nanjing Medical University, Nanjing, China.ORCID https://orcid.org/0000-0002-7831-8794
Yu HuangDepartment of Radiology, Brain Hospital Affiliated to Nanjing Medical University, Nanjing, China.
Chun-Duo XiaDepartment of Pathology, Brain Hospital Affiliated to Nanjing Medical University, Nanjing, China.
Hai-Qing ZhuDepartment of Pathology, Brain Hospital Affiliated to Nanjing Medical University, Nanjing, China.
Juan WangDepartment of Pathology, Brain Hospital Affiliated to Nanjing Medical University, Nanjing, China.
Nanjing Brain Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 16-year-old male was admitted to the hospital for weakness of both lower extremities. Magnetic resonance imaging revealed an intraspinal extramedullary subdural mass at the thoracic 9 level. Microscopically, the tumor cells were small to medium sized and round to ovoid in shape. They were distributed in diffuse sheets or showed nodular appearance. The nucleus of the tumor had mild-to-moderate atypia, with vesicular chromatin and prominent nucleoli. A smaller proportion of tumor cells demonstrated rhabdoid morphology. Focal myxoid stromal change was present, in which tumor cells exhibited spindle shapes. Approximately two mitoses were counted per 10 high-power fields. No necrosis was observed. The tumor cells were focal positive for CD99; multifocal positive for WT1; diffuse positive for nestin, synaptophysin, and D2-40; partial positive for GFAP; focal positive for desmin and SSTR2; and scattered positive for S-100 protein. The Ki-67 labeling index was approximately 20%. Genetic testing revealed CIC-LEUTX gene fusion. Considering the patient's history, clinical data, pathological findings and genetic findings, we rendered a rare tumor named CIC-rearranged sarcoma with CIC-LEUTX gene fusion.

Indexed as

Biomarkers, TumorSarcoma, Small CellAdolescentGene FusionHomeodomain ProteinsHumansMaleSpinal CordBiomarkers, TumorHomeodomain ProteinsLEUTX protein, humanCIC-LEUTX fusionimmunohistochemistryRNA-based next generation sequencingsarcomaspinal tumor

Identifiers

PMID35859319
PMCPMC10084232
OpenAlexW4286501641

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.